Testing abacavir/lamivudine for lupus
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This trial tests whether a combination of two antiviral drugs, abacavir and lamivudine, can help people with lupus. It’s for patients whose lupus is not very active and who do not have certain infections or gene types that could cause side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 65 years old and weigh more than 55 pounds (25 kg).
- You must have been diagnosed with systemic lupus erythematosus (SLE) using official criteria.
- Your lupus should be in remission or only mildly active (not severe).
- You cannot have the HLA-B*5701 gene (a blood test can check this).
- You cannot be pregnant, breastfeeding, or have chronic HIV, hepatitis B, or hepatitis C.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new drug called ABBV-519 given as infusions or injections to treat systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) in adults whose disease hasn't responded well to other treatments. Researchers will measure how safe the drug is, how it moves through your body, and whether it helps reduce symptoms.
This trial tests a new treatment, UB-VV410, for people with active systemic lupus erythematosus (SLE) or lupus nephritis (kidney inflammation caused by lupus) that hasn't responded to standard treatments. It aims to see if this therapy can help control the disease.
This study tests a new drug called LBL-047 in healthy people and in people with mild to moderate lupus. It helps check if the drug is safe and how the body processes it. Participating may help find better treatments for lupus.
This study tests an experimental daily pill (BI 3000202) for people with active lupus (SLE) to see if it can reduce disease activity. It compares different doses against a placebo, and you must already be on stable lupus background treatment.
This study tests an oral tablet (TQB3702) for people with lupus. It aims to see if the drug can help control lupus activity. It's for patients already on standard lupus treatments with stable disease.
This trial tests a new drug called SHR-2173 for people with active lupus. It aims to see if it can reduce disease activity when taken with standard treatments.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.